Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications.

Ricciuti, Biagio

Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 08 2019 - 1927-1934 p. digital

Publication Type: Comparative Study; Journal Article

1527-7755

10.1200/JCO.19.00189 doi


Adrenal Cortex Hormones--administration & dosage
Adult
Aged
Aged, 80 and over
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--complications
Disease Progression
Disease-Free Survival
Female
Humans
Immune System
Immunotherapy--methods
Lung Neoplasms--complications
Male
Middle Aged
Neoplasm Metastasis
Palliative Care--methods
Prednisone--administration & dosage
Proportional Hazards Models
Pulmonary Disease, Chronic Obstructive--complications
Radiation Pneumonitis--complications
Retrospective Studies
Treatment Outcome